We are live on ! Find out more
BSX icon

Boston Scientific

1,708 hedge funds and large institutions have $131B invested in Boston Scientific in 2025 Q3 according to their latest regulatory filings, with 179 funds opening new positions, 767 increasing their positions, 554 reducing their positions, and 132 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 767 | Existing positions reduced: 554

36% more first-time investments, than exits

New positions opened: 179 | Existing positions closed: 132

14% more call options, than puts

Call options by funds: $1.13B | Put options by funds: $989M

1% more funds holding

Funds holding: 1,6871,708 (+21)

0.86% less ownership

Funds ownership: 91.53%90.67% (-0.86%)

7% less funds holding in top 10

Funds holding in top 10: 4239 (-3)

10% less capital invested

Capital invested by funds: $145B → $131B (-$14.2B)

Holders
1,708
Holders Change
+21
Holders Change %
+1.24%
% of All Funds
22.41%
Holding in Top 10
39
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-7.14%
% of All Funds
0.51%
New
179
Increased
767
Reduced
554
Closed
132
Calls
$1.13B
Puts
$989M
Net Calls
+$140M
Net Calls Change
-$85.7M
Name Holding Trade Value Shares
Change
Change in
Stake
HI
426
Horizon Investments
North Carolina
$9.45M -$60.5K -584 -0.6%
Empower Advisory Group
427
Empower Advisory Group
Colorado
$9.45M +$213K +2,061 +2%
BP
428
BNP Paribas
France
$9.43M -$1.88M -18,141 -16%
FC
429
FACT Capital
New York
$9.36M -$4.98M -48,065 -33%
OQS
430
Occudo Quantitative Strategies
Florida
$9.31M +$1.12M +10,838 +13%
LOAMS
431
Lombard Odier Asset Management (Switzerland)
Switzerland
$9.13M +$2.58M +24,940 +36%
EAM
432
Exane Asset Management
France
$9.12M +$8.23M +79,463 New
RBI
433
Raiffeisen Bank International
Austria
$9.08M -$449K -4,332 -4%
KRS
434
Kentucky Retirement Systems
Kentucky
$9.05M -$152K -1,471 -2%
LSA
435
L & S Advisors
California
$8.89M +$1.96M +18,939 +26%
HC
436
Headland Capital
South Carolina
$8.85M +$96.9K +936 +1%
GAM
437
Generali Asset Management
Italy
$8.76M +$666K +6,433 +8%
Dodge & Cox
438
Dodge & Cox
California
$8.68M -$155K -1,500 -2%
CGH
439
Crossmark Global Holdings
Texas
$8.54M -$3.21K -31 -0%
SCM
440
Sirios Capital Management
Massachusetts
$8.53M -$258K -2,493 -3%
BFG
441
Bleakley Financial Group
New Jersey
$8.53M +$749K +7,232 +9%
HIMCH
442
Hartford Investment Management Co (HIMCO)
Connecticut
$8.49M -$256K -2,473 -3%
SA
443
Sanctuary Advisors
Indiana
$8.46M +$1.1M +10,602 +14%
BCM
444
Brasada Capital Management
Texas
$8.43M -$271K -2,621 -3%
QIM
445
Quest Investment Management
Oregon
$8.41M -$3.66M -35,363 -29%
SPC
446
Spirepoint Private Client
Florida
$8.4M +$420K +4,053 +5%
AF
447
Alerus Financial
North Dakota
$8.28M -$30.1K -291 -0.3%
NB
448
Norinchukin Bank
Japan
$8.24M +$159K +1,540 +2%
TAM
449
Thematics Asset Management
France
$8.14M +$753K +7,268 +10%
IMCOOI
450
Investment Management Corp of Ontario (IMCO)
Canada
$8.11M +$782K +7,549 +10%

BSX Hedge Fund Activity: Q3 2025 in Review

1,708 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2025, worth a combined $131B — down 9.8% from $145B a quarter earlier.

Buyers outnumbered sellers: 179 funds opened new BSX positions and 132 closed out — a net gain of 47 holders — while 767 added to existing stakes and 554 trimmed.

The largest buyer was Parnassus Investments, adding an estimated $711M. The largest seller was Wellington Management Group, cutting an estimated $1.86B.

  • 1,708 institutional investors held Boston Scientific (BSX) as of Q3 2025, up from 1,687 in Q2 2025.
  • Funds reported $131B of Boston Scientific stock for Q3 2025, down 9.8% quarter-over-quarter.
  • 179 funds opened new Boston Scientific positions in Q3 2025 and 132 closed out, a net change of +47 holders.
  • The largest Boston Scientific buyer in Q3 2025 was Parnassus Investments, an estimated $711M added.
  • The largest Boston Scientific seller in Q3 2025 was Wellington Management Group, an estimated $1.86B sold.

Based on aggregated 13F filings for Q3 2025.